Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

BACKGROUND & AIMS: The combination of ledipasvir and sofosbuvir has been approved for treatment of genotype 1 hepatitis C virus (HCV) infection, including an 8-week regimen for treatment-naïve patients without cirrhosis and a baseline level of HCV RNA <6 million IU/mL. We analyzed data from a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gastroenterology
Hlavní autoři: Terrault, Norah A., Zeuzem, Stefan, Di Bisceglie, Adrian M., Lim, Joseph K., Pockros, Paul J., Frazier, Lynn M., Kuo, Alexander, Lok, Anna S., Shiffman, Mitchell L., Ben Ari, Ziv, Akushevich, Lucy, Vainorius, Monika, Sulkowski, Mark S., Fried, Michael W., Nelson, David R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5300778/
https://ncbi.nlm.nih.gov/pubmed/27565882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2016.08.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky